Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1819
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-18T10:42:57.275773Z
status: published
lens: trace
sector: health
headline: Ambient Artificial Intelligent Scribes in Oncology: Impact on Clinician Experience and Documentation Burden
dek: PURPOSE Ambient artificial intelligence (AI) scribes, widely implemented to reduce clinician burden and dissatisfaction, are not optimized for oncology. We evaluated this technology at-scale at a high-volume cancer center. METHODS This prospective mixed-methods study used surveys, electronic health record (EHR), and utilization data to assess adoption, burden, and satisfaction with an ambient AI scribe that was implemented from June to September 2025. Descriptive statistics categorized clinicians as adopters (3+…
gain_title: Among oncology clinicians who completed both surveys, high or excessive note-writing time fell after the AI scribe rollout, and most postrollout respondents said they would recommend it.
problem_title: Despite enterprise-wide implementation and training, only about one in five oncology clinicians used the AI scribe, and measured note-closing and after-hours documentation changes were small or inconsistent.
trace_subject: Ambient AI scribe rollout at a high-volume cancer center
gain_reading: Among oncology clinicians who completed both surveys, high or excessive note-writing time fell after the AI scribe rollout, and most postrollout respondents said they would recommend it.
gain_evidence: showed a decrease in high/excessive note-writing time (78% v 60%; P = .043) | 73% reporting they would recommend the tool to colleagues
problem_reading: Despite enterprise-wide implementation and training, only about one in five oncology clinicians used the AI scribe, and measured note-closing and after-hours documentation changes were small or inconsistent.
problem_evidence: 190 (19.8%) of 958 clinicians used the tool
quick_read: A cancer center introduced an ambient AI scribe between June and September 2025 and studied it prospectively with surveys, electronic health record data, and utilization data. Fewer than one in five clinicians used it, and most users were physicians from medicine and surgery.

The results suggest the tool can be well received by those who use it, yet the objective workload data do not show a clear reduction in documentation burden. Why uptake was low and how to tailor the tool to oncology workflows remain open questions.
limitation: Adoption was low and survey samples were small (45 paired respondents, 77 postrollout), and the authors say adoption barriers and tool optimization still need study, so the results may not represent all oncology clinicians.
tag: Dual reading
key_points: 190 of 958 clinicians (19.8%) used the tool, including 124 adopters and 66 attempted adopters. | The likelihood of closing notes on visit days stayed at 70% for never-users and fell slightly for attempted adopters (73% to 70%) and adopters (56% to 54%). | Pajama time among adopters fell from 86.9 to 81.4 minutes per week, while attempted adopters stayed flat and never-users dropped from 69.5 to 62.2. | Among 45 clinicians completing both surveys, high or excessive note-writing time declined from 78% to 60%.
rundown: The study used a mixed-methods design combining surveys with EHR and utilization data. Clinicians were grouped as adopters (3 or more weeks of use), attempted adopters (1 to 2 weeks), or never-users, and generalized estimating equations tested the effect of adoption on note closing and pajama time.

Use was concentrated in new, video, and in-person visits. Adopters and attempted adopters were more often physicians from medicine and surgery, so uptake was uneven across clinician groups and visit types.

Postrollout surveys from 77 clinicians were largely positive, with 73% willing to recommend the tool. The authors describe the burden outcomes as mixed and call for research on adoption barriers and optimization for oncology documentation workflows.
sources:
- peer_reviewed | JCO Oncology Practice | https://doi.org/10.1200/op-26-00822 | 2026-10-17
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

d7a496d747d9228790e3d62b25ef317d7636017e83fa64d8d2a87844f07faaa2

previous

0000000000000000000000000000000000000000000000000000000000000000